Riskpilot← Back to searchSign inGet full accessPAACS BMI AS
ASActiveOrg 992249935Tuengen Allé 4A, 0374 OsloBusiness and other management consultancy activities · NACE 7020Est. 20080 employeeswww.bmioslo.no
Revenue 2024
NOK 0
EBITDA margin
—
+869% vs 2023
Equity ratio
78.8%
Financial strength
Net profit 2024
NOK 158K
+103% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK 158K | +869% |
| Net profit | NOK 158K | +103% |
| Total assets | NOK 251K | +241% |
| Equity | NOK 198K | +393% |
| Employees | 0 | — |
Legal name
PAACS BMI AS
Org number
992249935
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
29. januar 2008
Share capital
NOK 2 801 248
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Utvikling av medisinske, bioteknologiske, medisintekniske og velferdsteknologiske virksomheter. Formålet kan fremmes gjennom oppstart av selskaper, kjøp av andre virksomheter og teknologier og lisensiering av teknologier, ved deltagelse i eller samarbeid med andre foretak i inn og utland, og gjennom salg av konsulenttjenester til bioteknologiske eller medisinsk relaterte virksomheter.
Address
Tuengen Allé 4A, 0374 Oslo
Website
www.bmioslo.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −109 | −106 | −15 | −21 | 158 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −109 | −106 | −15 | −21 | 158 |
| Net financials | −0 | 0 | 0 | −4 517 | −0 |
| Profit before tax | −109 | −106 | −15 | −4 538 | 158 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −109 | −106 | −15 | −4 538 | 158 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 804 | 4 593 | 4 591 | 74 | 251 |
| Equity | 4 699 | 4 593 | 4 578 | 40 | 198 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 105 | 0 | 13 | 34 | 53 |
| Total debt | 105 | 0 | 13 | 34 | 53 |
EBITDA margin
15776900.0%
This company
15.8%
Market median
+99853697% vs market
20202024
Equity ratio
78.8%
This company
38.2%
Market median
+106% vs market
20202024
Return on equity
79.7%
This company
18.4%
Market median
+333% vs market
20202024
Net profit margin
15758600.0%
This company
8.1%
Market median
+194550517% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DW Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 88.48% | 88.48% | 2024 | |
| Individual | 11.52% | 11.52% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PAACS BMI AS 
REMOVAID ASBoard members of PAACS BMI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dag Wilhelm Ringvold Strømme | Chief Executive Officer | 0 companies |
| Masha Paule Nathalie Legris Strømme | Board of Directors | 0 companies |